Forecasting the Impact of Medicare Part D Drug Negotiations
Aug 31, 2023
19:15
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
David W. Johnson and Julie Murchinson forecast the regulatory and competitive industry implications of Medicare negotiating the prices for 10 drugs with pharmaceutical companies on the new episode of the 4sight Health Roundup podcast moderated by David Burda.
David W. Johnson is CEO of 4sight Health.
Julie Vaughan Murchinson is Partner of Transformation Capital and former CEO of Health Evolution.
David Burda is News Editor and Columnist of 4sight Health.